Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Active Pharmaceutical Ingredients CDMO Market Size, Trends, Analysis, and Outlook By Product (Traditional Active Pharmaceutical Ingredient (Traditional API), Highly Potent Active Pharmaceutical Ingredient (HP-API), Antibody Drug Conjugate (ADC), Others), By Synthesis (Synthetic, Biotech), By Drug (Innovative, Generics), By Application (Oncology, Hormonal, Glaucoma, Cardiovascular disease, Diabetes, Others), By Workflow (Clinical, Commercial), by Region, Country, Segment, and Companies, 2024-2030
... (Innovative, Generics), By Application (Oncology, Hormonal, Glaucoma, Cardiovascular disease, Diabetes, Others), By Workflow (Clinical, Commercial), by Region, Country, Segment, and Companies, 2024-2030 The global Active Pharmaceutical Ingredients CDMO market size is poised to register 7.13% ... Read More
-
Pharmaceutical CDMO Market Size, Trends, Analysis, and Outlook By Product (API), By Synthetic, Solid, Liquid), By Type (Traditional API, Highly Potent API, Antibody Drug Conjugate (ADC), Others), By Drug (Innovative, Generics), By Manufacturing (Continuous manufacturing, Batch manufacturing, Biotech, Drug Product, Oral solid dose, Semi-solid dose, Liquid dose, Others), By WorkFlow (Clinical, Commercial), By Application (Oncology, Hormonal, Glaucoma, Cardiovascular disease, Diabetes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Batch manufacturing, Biotech, Drug Product, Oral solid dose, Semi-solid dose, Liquid dose, Others), By WorkFlow (Clinical, Commercial), By Application (Oncology, Hormonal, Glaucoma, Cardiovascular disease, Diabetes, Others), by Region, Country, Segment, and Companies, 2024-2030 The global ... Read More
-
Pharmaceutical Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By ... Read More
-
Disease Management Apps Market Size, Trends, Analysis, and Outlook By Platform (iOS, Android, Others) ), By Device (Smartphones, Tablets, Wearables ), By Indication (Obesity, Cardiovascular Issues, Mental Health, Diabetes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Disease Management Apps market size is poised to register 10.7% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Endocrinology Drugs Market Size, Trends, Analysis, and Outlook By Therapy Area (Adrenal Insufficiency, Diabetes, Thyroid Hormone Disorder, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... global Endocrinology Drugs market size is poised to register 7.64% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Endocrinology Drugs market across ... Read More
-
Drug-Device Combination Products Market Size, Trends, Analysis, and Outlook By Products (Drug Eluting Stents, Transdermal Patches, Infusion Pumps, Drug Eluting Balloon, Inhalers, Others), By Application (Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... Ambulatory Surgical Centers, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Drug-Device Combination Products market size is poised to register 8.74% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Infusion Pump Market Size, Trends, Analysis, and Outlook By Product (Volumetric infusion pumps, non-dedicated accessories and consumables), By Type (Volumetric infusion pumps, Insulin pumps, Ambulatory infusion pumps, Syringe infusion pumps, Enteral infusion pumps, PCA pumps, Implantable infusion pumps), By Technology (Traditional infusion pumps, Specialty infusion pumps), By Mode, Stationary infusion pumps, Portable infusion pumps), By Application (Chemotherapy/oncology, Diabetes management, Gastroenterology, Analgesia/pain management, Pediatrics/neonatology, Hematology, Others), By Setting, Hospitals, Homecare Settings, Ambulatory care settings, Academic and research institutes), by Region, Country, Segment, and Companies, 2024-2030
... Implantable infusion pumps), By Technology (Traditional infusion pumps, Specialty infusion pumps), By Mode, Stationary infusion pumps, Portable infusion pumps), By Application (Chemotherapy/oncology, Diabetes management, Gastroenterology, Analgesia/pain management, Pediatrics/neonatology, Hematology, Others), By Setting, Hospitals, Homecare Settings, ... Read More
-
Intravenous Infusion Pump Market Size, Trends, Analysis, and Outlook By Product (Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Others), By Indication (Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Indication (Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Intravenous Infusion Pump market size is poised to register 7.53% growth from 2024 to 2030, presenting significant growth ... Read More
-
Active Wheelchair Market Size, Trends, Analysis, and Outlook By Product (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others), by Region, Country, Segment, and Companies, 2024-2030
... Cord Injury, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Active Wheelchair market size is poised to register 5.04% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Pharmaceutical Manufacturing Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)), By Drug Development (In-house, Outsource), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Route of Administration (Oral, Topical, Parenteral, Inhalations, Others), By Therapy Area (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, Others), By Prescription (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age group (Children & Adolescents, Adults, Geriatric), By Sales Channel (Retail, Non-retail), by Region, Country, Segment, and Companies, 2024-2030
... of Administration (Oral, Topical, Parenteral, Inhalations, Others), By Therapy Area (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, Others), By Prescription (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age group (Children & Adolescents, Adults, Geriatric), By Sales ... Read More
-
Recombinant Proteinrapeutics CDMO Market Size, Trends, Analysis, and Outlook By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source (Mammalian Systems, Microbial Systems, Others), By Indication (Oncology, Infectious Diseases, Immunological Disorders, Metabolic Disorders, Haematological Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Recombinant Proteinrapeutics CDMO market size is poised to register 12.58% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Self-testing Market Size, Trends, Analysis, and Outlook By Product (Kits, Devices, Strips), By Sample Type (Blood, Urine, Stool, Others), By Application (Blood Pressure Test, Diabetes and Glucose Tests, Cholesterol and Triglycerides Tests, Pregnancy Test, STD /STI Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others), By Distribution Channel (Online, Offline), By Usage (Disposable, Reusable), by Region, Country, Segment, and Companies, 2024-2030
... /STI Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others), By Distribution Channel (Online, Offline), By Usage (Disposable, Reusable), by Region, Country, Segment, and Companies, ... Read More
-
Generic Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Type (Simple Generics, Specialty Generics, Biosimilar), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals ... Read More
-
Lifestyle Diseases Apps Market Size, Trends, Analysis, and Outlook By Platform (iOS, Android, Others), By Device (Smartphones, Tablets, Wearables), By Indication (Obesity, Cardiovascular Health, Mental Health, Diabetes, Others), by Region, Country, Segment, and Companies, 2024-2030
... The global Lifestyle Diseases Apps market size is poised to register 13.11% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Lifestyle Diseases ... Read More
-
The 2025-2030 World Outlook for Human Insulin Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Smart Insulin Pens and Pumps
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Diabetic Care Devices
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Diabetes Monitoring, Treatment, and Drug Delivery Products
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Diabetes Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Diabetic Shoes
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Diabetic Foot Ulcer Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Diabetes Devices
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Human Insulin
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Human Insulin Drugs and Delivery Devices
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Diabetic Foot Ulcers and Pressure Ulcers
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
Research Assistance
